Latest Regulatory Approvals News

ALS Limited reported record FY26 financial results driven by strong growth in Minerals and Industrial Materials, while advancing its digital transformation through the Lab of the Future initiative. Leadership changes and a strategic portfolio review underpin its disciplined capital allocation approach.

Wide Open Agriculture (ASX: WOA) is executing a major strategic pivot by closing its German production site and transitioning to a capital-light contract manufacturing model to improve economics and scale lupin protein production.

Australian Strategic Materials (ASM) has announced a revised timetable for its shareholder scheme meetings tied to Energy Fuels’ acquisition, alongside dispatching a supplementary booklet that updates key transaction details including a new expert report. The acquisition now contemplates Energy Fuels’ conditional US$725 million financing and a US$1.9 billion deal to acquire VAC.

Lumos Diagnostics reported a 6% revenue increase to US$13.2 million for FY26, driven by an 875% surge in FebriDx® sales following a pivotal CLIA waiver. The company expanded U.S. adoption to 170+ healthcare sites and secured milestone payments exceeding US$6 million.

Lake Resources has raised A$3.8 million through an at-the-market placement priced above recent trading levels, earmarked for environmental and power optimisation work at its Kachi lithium project.

Santana Minerals has reported exceptional high-grade gold intercepts from infill drilling at its Rise and Shine orebody, including a standout 24.4m at 10.9 g/t Au and a deeper 2m section grading 89.5 g/t Au. These results enhance confidence in the deposit’s grade model and the upcoming mining schedule.

Firebrick Pharma expanded its patent portfolio with grants in Canada and New Zealand while achieving 43% sales growth in FY26 despite steady operating expenses. The company is advancing Nasodine's commercial rollout across Southeast Asia and the US.

EQT AB’s controlled entity has raised its indicative offer for Perpetual to A$22.50 per share, a modest increase contingent on the sale of Perpetual’s Wealth Management business and other conditions. The Perpetual Board remains undecided and has not recommended shareholder action.

BlinkLab has bolstered its war chest with a A$17.5 million placement, secured a foundational US patent valid through 2041, and made significant progress in its FDA autism diagnostic trial and European ADHD study.

Bannerman Energy advances Etango uranium project with early works on track and CNNC Overseas Limited investment nearing completion, targeting a positive Final Investment Decision in Q3 2026.

Prodigy Gold’s latest scoping study for the Hyperion Gold Project outlines a viable open pit operation with a 260,000-ounce production target and strong financial metrics. Meanwhile, exploration funding and ore sorting advances at Old Pirate support near-term development prospects.

Evolution Mining has agreed to acquire Carnaby Resources via a scheme of arrangement valuing Carnaby at around A$213 million, delivering a 60% premium to shareholders and aiming to de-risk the Greater Duchess project.